Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14998731rdf:typepubmed:Citationlld:pubmed
pubmed-article:14998731lifeskim:mentionsumls-concept:C0004927lld:lifeskim
pubmed-article:14998731lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:14998731lifeskim:mentionsumls-concept:C1505043lld:lifeskim
pubmed-article:14998731pubmed:issue1lld:pubmed
pubmed-article:14998731pubmed:dateCreated2004-3-4lld:pubmed
pubmed-article:14998731pubmed:abstractTextTranskarbam 12 (T12), the carbamic acid salt of omega-aminocaproic acid dodecyl ester, is a recently synthesized substance, whose high permeation enhancing activity through the human skin was found for certain drugs. In this work, the thermotropic phase behaviour of T12 has been studied by means of various techniques, namely, DSC, FTIR and FT-Raman spectroscopy, X-ray powder diffraction, and DRS. The temperature development of the X-ray reflections as well as of the conformationally sensitive Raman bands and the IR bands have been observed. At room temperature, the hydrocarbon chains of T12 exhibit a highly ordered structure, arranged in an orthorhombic perpendicular subcell. On heating, two transitions occur at 54 and at 66 degrees C. The first transition is related to the disruption of the carbamate structure and changes in the polar head group. The other transition represents the melting of hydrocarbon chains and the subsequent release of carbon dioxide. The time required for the rebinding of carbon dioxide and the reformation of the carbamate structure is dependent upon numerous factors and it was not possible to precisely determine the length of this process.lld:pubmed
pubmed-article:14998731pubmed:languageenglld:pubmed
pubmed-article:14998731pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14998731pubmed:citationSubsetIMlld:pubmed
pubmed-article:14998731pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14998731pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14998731pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14998731pubmed:statusMEDLINElld:pubmed
pubmed-article:14998731pubmed:monthAprlld:pubmed
pubmed-article:14998731pubmed:issn0009-3084lld:pubmed
pubmed-article:14998731pubmed:authorpubmed-author:NeubertReinha...lld:pubmed
pubmed-article:14998731pubmed:authorpubmed-author:WartewigSiegf...lld:pubmed
pubmed-article:14998731pubmed:authorpubmed-author:HrabálekAlexa...lld:pubmed
pubmed-article:14998731pubmed:authorpubmed-author:DolezalPavelPlld:pubmed
pubmed-article:14998731pubmed:authorpubmed-author:RaudenkolbSte...lld:pubmed
pubmed-article:14998731pubmed:authorpubmed-author:HübnerWigandWlld:pubmed
pubmed-article:14998731pubmed:authorpubmed-author:RettigWilliWlld:pubmed
pubmed-article:14998731pubmed:authorpubmed-author:ZbytovskáJarm...lld:pubmed
pubmed-article:14998731pubmed:authorpubmed-author:PissisPolycar...lld:pubmed
pubmed-article:14998731pubmed:issnTypePrintlld:pubmed
pubmed-article:14998731pubmed:volume129lld:pubmed
pubmed-article:14998731pubmed:ownerNLMlld:pubmed
pubmed-article:14998731pubmed:authorsCompleteYlld:pubmed
pubmed-article:14998731pubmed:pagination97-109lld:pubmed
pubmed-article:14998731pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14998731pubmed:meshHeadingpubmed-meshheading:14998731...lld:pubmed
pubmed-article:14998731pubmed:meshHeadingpubmed-meshheading:14998731...lld:pubmed
pubmed-article:14998731pubmed:meshHeadingpubmed-meshheading:14998731...lld:pubmed
pubmed-article:14998731pubmed:meshHeadingpubmed-meshheading:14998731...lld:pubmed
pubmed-article:14998731pubmed:meshHeadingpubmed-meshheading:14998731...lld:pubmed
pubmed-article:14998731pubmed:meshHeadingpubmed-meshheading:14998731...lld:pubmed
pubmed-article:14998731pubmed:meshHeadingpubmed-meshheading:14998731...lld:pubmed
pubmed-article:14998731pubmed:meshHeadingpubmed-meshheading:14998731...lld:pubmed
pubmed-article:14998731pubmed:meshHeadingpubmed-meshheading:14998731...lld:pubmed
pubmed-article:14998731pubmed:meshHeadingpubmed-meshheading:14998731...lld:pubmed
pubmed-article:14998731pubmed:year2004lld:pubmed
pubmed-article:14998731pubmed:articleTitlePhase behaviour of transkarbam 12.lld:pubmed
pubmed-article:14998731pubmed:affiliationFaculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic.lld:pubmed
pubmed-article:14998731pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14998731pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed